mike-thompson-blue-bg

ABPI Chief Executive Mike Thompson to retire by the end of 2019

pharmafile | July 5, 2019 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Mike Thompson, pharma 

The Association of the British Pharmaceutical Industry (ABPI) has announced that its Chief Executive Mike Thompson is to retire from his role by the end of this year.

His decision to leave the association marks the end of a three-year run beginning in March 2016, when stepped in to take up the mantle from Alison Clough, who had served as the acting Chief Executive for much of 2015.

Prior to this move, he served at major UK pharma firm GlaxoSmithKline as Seniuor Vice President of Global Commercial Strategy, the final role of a tenure last 20 years. During that time, he also serve as Commercial Strategy Head for Europe and a decade shouldering a range of senior sales and marketing positions in the UK Operating Company.

“This has been an extraordinary period to have had led the ABPI. Whilst the media has focussed on the challenges the country has faced, we can be proud of how we’ve used the dynamic to bring about positive change,” commented Thompson. “There is a lot more to say, particularly about the great people I’ve loved working with, but there will be time for that at the end of the year. I am making this announcement now so that there can be an open, and timely process to find my successor.”

Advertisement

The association announced that it would be recruiting for a replacement.  

Matt Fellows

Related Content

drug-trials

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence

LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …

blood_test

Johnson & Johnson announces successful results from trial for myeloma treatment

Global healthcare company, Johnson & Johnson, announced that analysis of its Darzalex (daratumumab) therapy showed …

Bend Bioscience adds commercial spray drying facility to Georgia site

Bend Bioscience has announced the addition of a commercial-scale spray dryer and a Gerteis dry …

The Gateway to Local Adoption Series

Latest content